ApexFlow
Back to Shop
Tirzepatide - Image 1
Available In Stock
Laboratory Certified

Tirzepatide

Dual GIP/GLP-1 agonist — the most powerful fat-loss peptide on the market.

4.9 Star Rating
2-4 Day Shipping
Secure Checkout
Insured & Discreet
99%+ High Purity

In-Vitro Reference: Specimen compounds are manufactured for specialized laboratory assay experiments, receptor-affinity profiling, and cellular pathways testing only. Unapproved for clinical dosage formulations.

Requires Bacteriostatic Water

This lyophilized powder must be reconstituted prior to assay work. If you do not have sterile bacteriostatic water, ensure to bundle it in your cart drawer.

SELECT CONCENTRATION (PER VIAL)

Select Purchase Option

Quantity

Single Box Price

109.00
💡

Smart Value Comparison

A Pack of 10 Vials costs the same as 4 individual vials (€116.00). By choosing the Pack of 10, you get 6 extra vials free and save 181.00.

Targeted Biometric Pathways

  • Targets two hunger-suppressing receptors simultaneously
  • Clinically shown to reduce body weight by up to 22%
  • Dramatically reduces appetite within the first week

100% Tracked EU Delivery Guarantee

Dispatched from our Portugal distribution hub. Every package has a 0% customs risk within the EU. In the extremely rare event of a transit issue, loss, or delay, we will reship your order free of charge.

Current Batch: MDL-TZ-2605
HPLC Verified: 99.42% Purity
Only a few units remaining

Express Shipping to European Union 🇪🇺EU-to-EU Only

Order now to receive by Jul 30 - Aug 3

Ships within 24h

About Tirzepatide

Description of Tirzepatide

Tirzepatide is a synthetic peptide containing 39 amino acids that acts as a dual agonist at both the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. By stimulating both GIP and GLP-1 receptors, Tirzepatide enhances insulin secretion, decreases glucagon levels, delays gastric emptying, and increases satiety. In robust clinical research (such as the SURMOUNT trial series), Tirzepatide demonstrated unmatched, dose-dependent reductions in body weight, outperforming selective GLP-1 agonists alone.

Research Confirmed Effects

1. Dual Agonist Synergy (GIP & GLP-1)

Standard weight management therapies historically targeted a single metabolic receptor pathway. GIP and GLP-1 are both natural incretin hormones secreted by the gut. While GLP-1 suppresses appetite and slows stomach emptying, GIP acts on fat cells and central receptors to modulate lipid metabolism and reduce nausea. Together, they act synergistically to reset metabolic setpoints, allowing research subjects to sustain significant weight loss without typical feedback resistance.

2. Unprecedented Weight Reduction Clinical Findings

In major phase-3 clinical trials, researchers observed average weight reductions of up to 22.5% in subjects treated with the highest dose (15mg once weekly) over a 72-week period. These findings represent a substantial breakthrough in therapeutic weight management, mimicking results previously only achievable via surgical interventions.

3. Glycemic Control & Insulin Sensitivity

Tirzepatide dramatically improves HbA1c levels in diabetic models. By enhancing glucose-dependent insulin release from the pancreas, it stabilizes blood sugar levels post-meal without causing hypoglycemia under baseline fasting states. It also downregulates fat storage processes by improving muscular and hepatic insulin responsiveness.

References

A. M. Jastreboff et al., “Tirzepatide Once Weekly for the Treatment of Obesity,” N. Engl. J. Med., vol. 387, no. 3, pp. 205-217, 2022.

F. Caro et al., “The role of dual GIP/GLP-1 receptor agonists in metabolic health,” Lancet Diabetes Endocrinol, vol. 11, no. 5, pp. 344-356, 2023.

Standard Protocol Reference

Titration: 2.5mg for 4 weeks → 5.0mg for 4 weeks → up to 15mg maintenance (Once Weekly).

Reconstitution & Dosing

Suggested Usage: Titration: 2.5mg for 4 weeks → 5.0mg for 4 weeks → up to 15mg maintenance (Once Weekly).

Estimated Delivery

2–4 Business Days

Free Premium EU Shipping

Assay Prep Method

Lyophilized Unit

Reconstitute with Sterile Water

Peptide Formulation

Pure Freeze-Dried Powder

Vacuum Sealed Inert gas vial

Technical Formulation Specifications

CAS Number2023788-19-2
Molecular Mass4813.53 g/mol
Amino Acid SequenceTyr-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-Aib-Leu-Asp-Lys-Ile-Ala-Gln-Lys-Ala-Phe-Val-Gln-Trp-Leu-Ile-Ala-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-Lys (C-term amide, Lys20 conjugated to C20 diacid)
Solubility ProfileSterile / Bacteriostatic water 1ml/vial
Unboxing

Vial Research Pack: What's In The Box

Every shipment comes with all necessary sterile instruments and instructional reference protocols.

10x Sterile Vials

Standard borosilicate vials each containing pure freeze-dried cake (5 mg/vial).

Vacuum Sealed

Vials are sealed under high-vacuum inert gas atmosphere to prevent oxidation.

Assay Protocol Guide

Aseptic preparation booklet, dose increments, and cold chain handling guides.

Cold-Wrap Insulating

Packed in thermal foil with cold gel packs to maintain refrigeration during transit.

Market Comparison

Why Researchers Choose Our Vials

A side-by-side comparison of ApexFlow (MDL) against standard market alternatives.

Research FactorMDL Lyophilized VialsStandard Chinese/Generic Vials
Purity & Quality✅ 99.4%+ HPLC Verified. Every single batch is independently tested with accessible COA.❌ Unverified purity. Frequently underdosed, degraded, or contains synthesis impurities.
Delivery & Customs✅ Shipped from Portugal. 0% customs risk within EU. 100% arrival rate or free reshipment.❌ Shipped from China/US. High risk of customs seizure, long shipping delays, no refund.
Ease of Use✅ High-vacuum sealed cake. Rapidly reconstitutes in <30s. Zero residues.❌ Loose powder cakes with moisture contamination. Hard to dissolve, forms foam/clumps.
Safety & Integrity✅ Sealed under inert gas. Insulated cold-wrap transport. 100% sterile manufacturing.❌ Loose vial rubber stoppers. Exposed to excessive heat in cargo holds, degrading potency.

99%+ Purity

HPLC Verified

3rd Party Tested

COA Available

Discreet Packaging

Sealed & Secure

Free EU Shipping

2–4 Business Days

Protocol Reference

How to Use & Reconstitute

Follow these standard laboratory protocols for handling the lyophilized peptide vial.

01

Sanitize Stoppers

Clean your hands, then wipe down the rubber stoppers of both the peptide vial and the sterile Bacteriostatic Water vial.

02

Slow Reconstitution

Draw 1-2ml of Bacteriostatic Water. Direct the needle at an angle down the glass wall so the water slowly slides down without foaming.

03

Gently Dissolve

Swirl the vial in slow, circular motions until the lyophilized powder completely dissolves. Never shake, to protect peptide chains.

04

Refrigerate Solution

Store the reconstituted solution in the refrigerator at 2–8°C. For maximum stability and assay integrity, use within 28 days.

Logistics Pipeline

Discreet Cold-Wrap Delivery

Every shipment is optimized for compound stability and absolute researcher privacy.

1

Lab Verification

Vials are batch-tested via HPLC/MS. They are vacuum sealed under inert gas and wrapped in protective thermal insulating layers to maintain structural stability.

2

Stealth Packing

Orders are packed in robust, plain cardboard boxes. There is no mention of 'peptides', 'lab', or chemical terms on the outside for absolute confidentiality.

3

Direct EU Transit

Dispatched from our Portugal distribution hub. Fully tracked express delivery across the EU with zero customs holds and 100% arrival rate.

Excellent
4.9 / 5.0 rating based on verified customer photos

Best GLP-1 alternative

"I switched to Retatrutide and the appetite suppression is on another level. Dropped the stubborn weight I couldn't lose before."

Verified Review • Dominik S.

Exceptional purity

"I've tried other vendors for peptides but the quality here is top tier. Shipping was fast and the product is perfectly clear."

Verified Review • Anna K.
Arrived in 3 days! Super fast
Customer Photo

Arrived in 3 days! Super fast

"Unbelievable shipping speed to Europe. The vials were packaged with extreme care. Purity is clear and absolutely pristine."

Verified Purchase • Niklas B.

Description of Tirzepatide

Tirzepatide is a synthetic peptide containing 39 amino acids that acts as a dual agonist at both the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. By stimulating both GIP and GLP-1 receptors, Tirzepatide enhances insulin secretion, decreases glucagon levels, delays gastric emptying, and increases satiety. In robust clinical research (such as the SURMOUNT trial series), Tirzepatide demonstrated unmatched, dose-dependent reductions in body weight, outperforming selective GLP-1 agonists alone.

Research Confirmed Effects

1. Dual Agonist Synergy (GIP & GLP-1)

Standard weight management therapies historically targeted a single metabolic receptor pathway. GIP and GLP-1 are both natural incretin hormones secreted by the gut. While GLP-1 suppresses appetite and slows stomach emptying, GIP acts on fat cells and central receptors to modulate lipid metabolism and reduce nausea. Together, they act synergistically to reset metabolic setpoints, allowing research subjects to sustain significant weight loss without typical feedback resistance.

2. Unprecedented Weight Reduction Clinical Findings

In major phase-3 clinical trials, researchers observed average weight reductions of up to 22.5% in subjects treated with the highest dose (15mg once weekly) over a 72-week period. These findings represent a substantial breakthrough in therapeutic weight management, mimicking results previously only achievable via surgical interventions.

3. Glycemic Control & Insulin Sensitivity

Tirzepatide dramatically improves HbA1c levels in diabetic models. By enhancing glucose-dependent insulin release from the pancreas, it stabilizes blood sugar levels post-meal without causing hypoglycemia under baseline fasting states. It also downregulates fat storage processes by improving muscular and hepatic insulin responsiveness.

References

A. M. Jastreboff et al., “Tirzepatide Once Weekly for the Treatment of Obesity,” N. Engl. J. Med., vol. 387, no. 3, pp. 205-217, 2022.

F. Caro et al., “The role of dual GIP/GLP-1 receptor agonists in metabolic health,” Lancet Diabetes Endocrinol, vol. 11, no. 5, pp. 344-356, 2023.

Frequently Bought Together

Bacteriostatic Water
Bacteriostatic Water

Sterile bacteriostatic water for safe, multi-use peptide reconstitution.

Starting from20.00
View Unit
Semaglutide
Semaglutide

The original blockbuster GLP-1 — proven, trusted, and highly effective.

Starting from89.00
View Unit
Retatrutide
Retatrutide

Next-gen triple agonist — the most advanced fat-burning peptide available.

Starting from159.00
View Unit